Action potentials, contraction, and membrane currents in guinea pig ventricular preparations treated with the antispasmodic agent terodiline

Journal of Pharmacology and Experimental Therapeutics

Volumn 290, Issue 3, 1999, Pages 1417-1426

  Shuba, Lesya M ^a   Kasamaki, Yuji ^b   Jones, Stephen E ^a   Ogura, Toshitsugu ^a   McCullough, John R ^c   McDonald, Terence F ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c SUNOVION PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; POTASSIUM; SPASMOLYTIC AGENT; TERODILINE;

ACTION POTENTIAL; ANIMAL TISSUE; ARTICLE; BRADYCARDIA; CALCIUM CURRENT; GUINEA PIG; HEART VENTRICLE CONTRACTION; HEART VENTRICLE TACHYCARDIA; INOTROPISM; MEMBRANE CURRENT; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; QT INTERVAL; URINE INCONTINENCE; VOLTAGE CLAMP;

ACTION POTENTIALS; ANIMALS; BUTYLAMINES; CALCIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; GUINEA PIGS; HEART VENTRICLES; MEMBRANE POTENTIALS; MYOCARDIAL CONTRACTION; PAPILLARY MUSCLES; PARASYMPATHOLYTICS; POTASSIUM;

EID: 0032813029     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Baer M, Best PM and Reuter H (1976) Voltage-dependent action of tetrodotoxin in mammalian cardiac muscle. Nature (Lond) 263:344-345.
2. Berul CI and Morad M (1995) Regulation of potassium channels by non-sedating antihistamines. Circulation 91:2220-2225.
3. + currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ Res 73:379-385.
4. Campbell TJ (1987) Cellular electrophysiological effects of D- and DL-sotalol in guinea-pig sinoatrial node, atrium and ventricle and human atrium: Differential tissue sensitivity. Br J Pharmacol 90:593-599.
5. Castenfors H, Hedenstierna G and Glenne PO (1975) Pilot study of the effect of terodiline chloride (Bicor) in obstructive pulmonary disease. Eur J Clin Pharmacol 8:197-200.
6. Cingolani HE, Wiedmann RT, Lynch JJ, Baskin EP and Stein RB (1991) Myocardial contractile behaviour of a new sotalol derivative. J Cardiovasc Pharmacol 17:83-89.
7. 2+ exchange, and intracellular calcium release in rat ventricular myocytes. Ann NY Acad Sci 779:417-428.
8. Connolly MJ, Astridge PS, White EG, Morley CA and Cowan JC (1991) Torsades de pointes ventricular tachycardia and terodiline. Lancet 338:344-345.
9. Daleau P, Lessard E, Groleau MF and Turgeon J (1995) Erythromycin blocks the rapid component of the delayed rectifier potassium current and lengthens repolarization of guinea pig ventricular myocytes. Circulation 91:3010-3016.
10. Elmér M (1984) Terodiline in children with diurnal enuresis. Scand J Urol Nephrol Suppl 87:59-61.
11. K, by flecainide and E-4031 in cat ventricular myocytes. Circulation 82:289-293.
12. 2+ influx during the cardiac action potential in guinea pig ventricular myocytes. Circ Res 79:194-200.
13. Hayashi H, Ponnambalam C and McDonald TF (1987) Arrhythmic activity in reoxygenated guinea pig papillary muscles and ventricular cells. Circ Res 61:124-133.
14. Husted S, Andersson K-E, Sommer L and Østergaard JR (1980) Anticholinergic and calcium antagonistic effects of terodiline in rabbit urinary bladder. Acta Pharmacol Toxicol 46:20-30.
15. Imaizumi Y and Giles WR (1987) Quinidine-induced inhibition of transient outward current in cardiac muscle. Am J Physiol 253:H704-H708.
16. Iravani J and Melville GN (1975) Wirkung von Terodilin auf die Bronchialmuskulatur und die tracheobronchiale Reinigung der Ratte. Arzneim Forsch 25:415-417.
17. Jackman WM, Friday KJ, Anderson JL, Aliot EM, Clark M and Lazzara R (1988) The long QT syndromes: A critical review, new clinical observations and a unifying hypothesis. Progr Cardiovasc Dis 31:115-172.
18. January CT and Shorofsky S (1990) Early afterdepolarizations: Newer insights into cellular mechanisms. J Cardiovasc Electrophysiol 1:161-169.
19. + current by therapeutic concentrations of the antispasmodic agent terodiline. Br J Pharmacol 125:1138-1143.
20. + currents in pacemaker activity in the sinoatrial node. Am J Physiol 272:H2793-H2806.
21. Kura H, Yoshino M and Yabu H (1992) Blocking action of terodiline on calcium channels in single smooth muscle cells of the guinea pig urinary bladder. J Pharmacol Exp Ther 261:724-729.
22. Langtry HD and McTavish D (1990) Terodiline: A review of its pharmacological properties, and therapeutic use in the treatment of urinary incontinence. Drugs 40:748-761.
23. Munk AA, Adjemian RA, Zhao J, Ogbaghebriel A and Shrier A (1996) Electrophysiological properites of morphologically distinct cells isolated from the rabbit atrioventricular node. J Physiol (Lond) 193:801-818.
24. Natsukawa T, Matsuzaki T, Hayashi S, Ukai Y, Yoshikuni Y and Kimura K (1998) Comparison of the effects of NS-21 and terodiline on the QTc interval in dogs. Gen Pharmacol 30:137-142.
25. Nattel S, Ranger S, Talajic M, Lemery R and Roy D (1990) Erythromycin-induced long QT syndrome: Concordance with quinidine and underlying cellular electrophysiologic mechanism. Am J Med 89:235-238.
26. Nawrath H (1981) Action potential, membrane currents and force of contraction in mammalian heart muscle fibers treated with quinidine. J Pharmacol Exp Ther 216:176-182.
27. Ogura T, Shuba LM and McDonald TF (1995) Action potentials, ionic currents and cell water in guinea pig ventricular preparations exposed to dimethyl sulfoxide. J Pharmacol Exp Ther 273:1273-1286.
28. + current in sinoatrial node pacemaker activity. Am J Physiol 269:H453-H462.
29. Peters D (1984) Terodiline in the treatment of urinary frequency and motor urge incontinence: A controlled multicentre trial. Scand J Urol Nephrol 87:21-33.
30. Pressler ML, Warner MR, Rubart M, Rardon DP and Zipes DP (1995) In vivo and in vitro electrophysiologic effects of terodiline on dog myocardium. J Cardiovasc Electrophysiol 6:443-454.
31. Roden DM, Lazzara R, Rosen M, Schwartz PJ, Towbin J and Vincent GM (1996) Multiple mechanisms in the long-QT syndrome: Current knowledge, gaps, and future directions. Circulation 94:1996-2012.
32. Salata JJ, Jurkiewicz NK, Wallace AA, Stupienski RF, Guinosso PJ and Lynch JJ (1995) Cardiac electrophysiological actions of the histamine H1-receptor antagonists astemizole and terfenadine compared with chlorpheniramine. Circ Res 76: 110-119.
33. + current: Differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol 96:195-215.
34. + currents. Pfluegers Arch 420:180-186.
35. Shuba LM and McDonald TF (1994) Excitation-contraction coupling: Relationship of calcium currents to contraction, in Physiology and Pathophysiology of the Heart (Sperelakis N ed), 3rd ed., pp 259-277, Kluwer, Boston.
36. Sicouri S and Antzeleviteh C (1993) Drug-induced afterdepolarizations and triggered activity occur in a discrete sub-population of ventricular muscle cells (M cells) in the canine heart: Quinidine and digitalis. J Cardiovasc Electrophysiol 4:48-58.
37. Starmer CF, Lastra AA, Nesterenko VV and Grant AO (1991) Proarrhythmic response to sodium channel blockade: Theoretical model and numerical experiments. Circulation 84:1364-1377.
38. Stewart DA, Taylor J, Ghosh S, Macphee GJA, Abdullah I, McLenachan JM and Stott DJ (1992) Terodiline causes polymorphic ventricular tachycardia due to reduced heart rate and prolongation of QT interval. Eur J Clin Pharmacol 42:577-580.
39. Take K, Okumura K, Tsubaki K, Taniguchi K, Terai T and Shiokawa Y (1996) Agents for the treatment of overactive detrusor. V. Synthesis and inhibitory activity on detrusor contraction of N-tert-butyl-4,4-diphenyl-2-cyclopentenylamine. Chem Pharm Bull Tokyo 44:1858-1864.
40. Thomas SHL, Higham PD, Hartigan-Go K, Kamali F, Wood P, Campbell RWF and Ford GA (1995) Concentration dependent cardiotoxicity of terodiline in patients treated for urinary incontinence. Br Heart J 74:53-56.
41. + current activation in guinea pig ventricular myocytes. Circ Res 74:687-699.
42. Wallace AA, Stupienski RF, Brooks LM, Selnick HG, Claremon DA and Lynch JJ (1991) Cardiac electrophysiologic and inotropic actions of new and potent methanesulfonanilide class III antiarrhythmic agents in anesthetized dogs. J Cardiovasc Pharmacol 18:687-695.
43. Woosley RL (1996) Cardiac actions of antihistamines. Annu Rev Pharmacol Toxicol 36:233-252.